Selecta Biosciences: A Promising Player in Immunomodulatory Drug Development
May 10, 2023 - Biopharmaceutical company Selecta Biosciences (NASDAQ:SELB) opened at $1.18 a share on Wednesday. The company's current ratio ...
Tag: SELB
Selecta Biosciences Downgraded from Buy to Hold: Implications for Future Investment Prospects
Investors and market analysts are paying close attention to the recent changes in the rating of Selecta Biosciences (NASDAQ:SELB) issued ...